The Maryland Supreme Court has vacated Baltimore’s $266 million opioid verdict and sent the case back to circuit court.

A fictionalized case of an ER patient reducing a $3,100 bill to $280 spotlights the growing importance of negotiation and financial assistance in healthcare. Rising insurance premiums, hospital costs, ...

In a remarkable display of unity, independent candidate Apexa Soni secured a win in Godhra's communally sensitive Ward 7, a ...

A Maryland Supreme Court decision vacating a $152 million opioid verdict is not expected to change Baltimore’s immediate ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

The Federal Trade Commission (FTC) is signaling that health care and life sciences companies should expect heightened regulatory scrutiny related ...

Soaring premiums and new transparency rules are pushing companies to seek cheaper, nontraditional health insurers and ...

Democrat and Republican members alike criticized pharmacy benefit managers, who they say profit from driving up drug costs.

Employers, lawmakers and more said regulators should hustle to get disclosure mandates for the controversial drug middlemen ...